Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma

一致性 胰腺导管腺癌 病理 医学 腺癌 肿瘤科 生物 内科学 胰腺癌 癌症
作者
Fergus Keane,Lily V. Saadat,Catherine O’Connor,Joanne F. Chou,Anita S. Bowman,Fei Xu,Fionnuala Crowley,Neha Debnath,Joshua D. Schoenfeld,Anupriya Singhal,Drew Moss,Darren Cowzer,Emily Harrold,Wungki Park,Anna M. Varghese,Fiyinfolu Balogun,Kenneth H. Yu,Alice Zervoudakis,Marinela Capanu,Michael F. Berger
出处
期刊:Journal of the National Cancer Institute [Oxford University Press]
卷期号:117 (9): 1848-1857 被引量:2
标识
DOI:10.1093/jnci/djaf139
摘要

BACKGROUND: The utility of circulating tumor DNA (ctDNA) in addressing challenges of molecular tissue profiling and complementing next-generation sequencing is undefined in pancreas ductal adenocarcinoma. The objective of this study was to assess ctDNA detection rates by stage, disease burden, and metastasis patterns; compare overall survival between ctDNA-positive and ctDNA-negative patients cases; and determine concordance between ctDNA and matched-tissue biopsies. METHODS: Patients with pancreas ductal adenocarcinoma who had undergone Next Generation Sequencing by the MSK-ACCESS (Memorial Sloan Kettering - Analysis of Circulating cfDNA to Evaluate Somatic Status) ctDNA assay between 2019 and 2022 were included. Clinical and survival data were abstracted from a prospectively maintained clinical database. RESULTS: A total of 414 patients with pancreas ductal adenocarcinoma: 28% stage I-II, 21% stage III, 51% stage IV. ctDNA detection was highest among patients with advanced disease: 75% stage IV, 38% stage III, 34% stage I-II disease. For stage IV, ctDNA was more frequently detected in patients with at least 2 organs involved vs with less than 2 organs involved (76% vs 38%, P = .025). Higher rates of ctDNA detection were observed in patients with liver metastases vs without (82% vs 52%, P < .001). In the untreated stage IV cohort (n = 120), median overall survival was 10 months for those with detectable ctDNA (95% CI = 6.9 to 14 months) vs 19 months (95% CI = 13 months to not reached) for those with undetectable ctDNA (P = .1). Concordance between ctDNA and matched tissue next-generation sequencing was lower in untreated stage I-III disease, but high for untreated stage IV pancreas ductal adenocarcinoma, including a critical success index of 93.1% of KRAS variants. CONCLUSION: ctDNA is a promising tool in the detection of somatic variants in pancreas ductal adenocarcinoma. Concordance between ctDNA and tissue is high for patients with untreated metastatic disease, notably for detection of KRAS variants.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
WANG同学完成签到,获得积分10
刚刚
westernline完成签到,获得积分10
1秒前
俊逸的伟帮完成签到,获得积分10
1秒前
无极微光的应助被专一的书雪采纳,获得20
1秒前
领导范儿的应助被嘻嘻采纳,获得30
1秒前
vegdog完成签到,获得积分10
1秒前
tsy818发布了新的文献求助50
2秒前
聪慧樱发布了新的文献求助10
2秒前
2秒前
哈基咪发布了新的文献求助10
2秒前
池安完成签到 ,获得积分10
2秒前
科研通AI6.2的应助被ZJJ35采纳,获得10
2秒前
lucky完成签到 ,获得积分10
3秒前
cdercder的应助被okok采纳,获得10
4秒前
4秒前
5秒前
SciGPT的应助被jht456采纳,获得10
5秒前
5秒前
小蜜蜂发布了新的文献求助10
7秒前
你真是那个啊完成签到,获得积分10
7秒前
奶酪完成签到 ,获得积分10
7秒前
云糯发布了新的文献求助30
7秒前
shenmolianzzz发布了新的文献求助10
8秒前
小苏完成签到,获得积分10
9秒前
Alfred发布了新的文献求助10
9秒前
9秒前
George完成签到,获得积分10
9秒前
Patti完成签到,获得积分10
9秒前
从容问柳发布了新的文献求助10
11秒前
大神瓜完成签到,获得积分10
11秒前
CC66发布了新的文献求助10
11秒前
茯苓薏米茶完成签到,获得积分10
12秒前
256321完成签到,获得积分10
12秒前
13秒前
14秒前
14秒前
14秒前
sxxx完成签到,获得积分10
15秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186012
求助须知:如何正确求助?哪些是违规求助? 9574616
关于积分的说明 21837084
捐赠科研通 7783730
什么是DOI,文献DOI怎么找? 3434729
关于科研通互助平台的介绍 2559055
邀请新用户注册赠送积分活动 2481504